Harvard

Diabetes Mellitus (Type 1) May Have New Treatment Options

Diabetes Mellitus (Type 1), also known as insulin-dependent diabetes, and juvenile diabetes, affects approximately 3 million people nationwide, at a cost of nearly $15 billion annually. Type 1 diabetes is an autoimmune condition that involves the body’s autoimmune destruction of the insulin producing beta cells in the pancreas. The inability to produce insulin effectively leads […]

Read More